BALAXI - Balaxi Pharmaceuticals

Balaxi Pharmaceuticals

BALAXI · Retail > Trading · MD: Ashish Maheshwari · Listing date: Nov. 30, 2015 · Hyderabad · http://www.balaxiventures.in/

Stock Price vs Company Growth

6.8%

10.1%

5.3%

32.6%

38.0%

12.1%

35.1%

all

44.1%

🤔 How to analyze this graph?

Last Traded Price

₹ 74.7 6.8%

73.3

113

Company Overview

Sales

264 Cr

Growth: -12.4%

Profit after Tax

32.9 Cr

Growth: -11.3%

Micro Cap

413 Cr

P/E: 11.1x

Industry P/E: 27.9x

Fundamentals

Sales (Cr)	₹ 264
Growth	-12.4%
EBITDA	18.1%
P/S	1.6x
Dividend	0.0%
P/E	11.1x
Book Value	₹ 29.1
PEG Ratio	-0.9x
ROE	21.8%
P/B	2.6x

Shareholding Pattern

Institutions

Elara India Opportunities Fund Limited

9.5 %

Marshal Global Capital Fund Ltd

9.5 %

Amol Anand Mantri

1.73 %

Iepf

0.75 %

Promoters

Balaxi Overseas Private Limited

70.0 %

Ashish Maheshwari

1.81 %

Minoshi Maheshwari

1.06 %

Others

Increase Decrease No change

Company Profile Detailed

The company is engaged in the business of international wholesale trading of Pharmaceuticals, Builders Hardware and FMCG productsHistory and Milestones2003-07Commenced Pharmaceutcal business by supplying white labeled products to customers in Africa.Sourcing was from WHO GMP certified plants based in India.2008-10Created frontend presence for its Pharmaceutical Business by setting up 1st wholesale depot in Angola in 2008.

Investors (12)

elara.in...

balaxi.o...

ashish.m...

Followers (1)

gmuralik